Dr Adrian Reynolds. E-cigarettes: 'What do we know and what don't we know?'

Dr Adrian Reynolds. E-cigarettes: 'What do we know and what don't we know?'



Sydney Addiction Seminar debate, 21 November 2017
“Vaping nicotine – harm reduction, medical treatment, or public health risk?”

source

2 thoughts on “Dr Adrian Reynolds. E-cigarettes: 'What do we know and what don't we know?'

  1. Dear Dr Reynolds: electronic cigarettes are not "therapeutic" and are not medication. As long as they are not toxic, and they are not toxic, all your excessive caution on youth and marketing are irrelevant. People will never be "free from addiction". Abstinence only does not work. Deal with it. And BTW, the term "addiction" has much more angles than the strictly pharmacological one. Your extreme cautionary approach is really not based on evidence. You are simply counting how many articles "in favor" and how many "against", which is a very flawed approach to evaluate evidence because not all articles have the same quality and scope. You cannot cite, for example, the Karkhoran & Glantz study as a sort of "counterbalance" to the Zhu et al study, because the former is methodologically flawed and the latter is not (besides the size of the sample). Articles reporting on stiffness of arteries and other cardiovascular issues also have methodological issues. I strongly suspect that your extreme caution is not really based on hard evidence but on deep conservatism, on fear of admitting evidence that implies adopting new paradigms.

Comments are closed.